In this discussion with Matthew D. Park, a pioneering immunologist, listeners dive into how aging immune cells may inadvertently fuel cancer growth. Park reveals that myeloid cells can suppress cancer-fighting mechanisms as we age. He also explores how existing medications could reset this harmful process and transform cancer treatment, especially for lung cancer. The conversation highlights innovative strategies, including repurposed drugs like Anakinra, that could revolutionize care for high-risk patients.